Skip to main content

9 Meters Biopharma, Inc.

NMTRDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001551986

9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by 9 Meters Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for 9 Meters Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for 9 Meters Biopharma, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sensenig BethanyChief Financial Officer41,077Apr 21, 20230
Johnson Lorin KDirector12,125Mar 31, 20230
Sirgo Mark ADirector85,907Mar 31, 20230
Rice Yehuda MichaelDirector7,885Mar 31, 20230
Constantino Michael T.Director10,911Mar 31, 20230
Ventimiglia SamanthaDirector7,885Mar 31, 20230
Temperato JohnChief Executive Officer140,192Mar 29, 20230
Sitar Edward JChief Financial Officer194,338Sep 15, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 21, 2023 (view filing)Apr 21Same daySensenig BethanyChief Financial OfficerSSale−9.10K$1.21−$11.0K−18.1%41.1K after
Jul 8, 2022 (view filing)8:01 AM ETJul 62 daysTemperato JohnChief Executive OfficerPPurchase+125.0K$0.2277+$28.5K+9.6%1.43M after
May 24, 2022 (view filing)4:01 PM ETMay 231 dayConstantino Michael T.DirectorPPurchase+16.0K$0.4755+$7.61K+35.9%60.5K after
May 19, 2022 (view filing)4:09 PM ETMay 181 dayTemperato JohnChief Executive OfficerPPurchase+50.0K$0.4457+$22.3K+4.0%1.30M after
May 19, 2022 (view filing)4:01 PM ETMay 181 daySirgo Mark ADirectorPPurchase+106.4K$0.47+$50.0K+8.3%1.39M after
Mar 21, 2022 (view filing)Aug 20, 2020578 daysConstantino Michael T.DirectorPPurchase+26.5K$0.75+$19.9KNew position26.5K afterAmended
Mar 7, 2022 (view filing)Mar 34 daysSirgo Mark ADirectorPPurchase+86.4K$0.58+$50.1K+7.2%1.28M after
Mar 4, 2022 (view filing)Mar 31 dayTemperato JohnChief Executive OfficerPPurchase+100.0K$0.56+$56.0K+8.7%1.25M after
Dec 3, 2021 (view filing)Dec 21 daySirgo Mark ADirectorPPurchase+50.0K$0.89+$44.5K+4.2%1.24M after
Nov 22, 2021 (view filing)Nov 184 daysSirgo Mark ADirectorPPurchase+20.0K$1.06+$21.2K+1.7%1.19M after
Nov 19, 2021 (view filing)Nov 181 dayTemperato JohnChief Executive OfficerPPurchase+50.0K$1.05+$52.5K+4.5%1.15M after
Sep 15, 2021 (view filing)Sep 141 daySitar Edward JChief Financial OfficerPPurchase+15.0K$1.22+$18.3K+8.4%194.3K after
Sep 8, 2021 (view filing)Sep 71 daySirgo Mark ADirectorPPurchase+73.5K$1.36+$100.0K+6.7%1.17M after
Aug 26, 2021 (view filing)Aug 242 daysConstantino Michael T.DirectorPPurchase+18.0K$1.14+$20.5K+52.8%52.1K after
Aug 23, 2021 (view filing)Aug 203 daysSirgo Mark ADirectorPPurchase+25.0K$1.10+$27.5K+2.3%1.10M after
Aug 19, 2021 (view filing)Aug 181 dayTemperato JohnChief Executive OfficerPPurchase+25.0K$1.05+$26.3K+2.3%1.10M after